You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TAF1

Showing 1 - 25 of 302
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial (B/F/TAF)

Not yet recruiting
  • HIV-1-infection
  • (no location specified)
Oct 23, 2023

HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Dec 19, 2022

HIV-1-infection Trial (Delstrigo, KOCITAF)

Not yet recruiting
  • HIV-1-infection
  • (no location specified)
Jun 20, 2023

HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)

Terminated
Has Results
  • HIV-1-infection
  • Edmonton, Alberta, Canada
    University of Alberta
Nov 21, 2022

HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

Recruiting
  • HIV-1-infection
  • B/F/TAF
  • TDF-based triple ART regimen switching to B/F/TAF
  • Shanghai, Shanghai, China
  • +2 more
Dec 1, 2022

HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to DOR/ISL)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Jan 20, 2023

HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)

Completed
  • HIV-1-infection
  • BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
  • Madrid, Spain
    Hospital FUNDACIÓN JIMÉNEZ DÍAZ
Nov 2, 2022

HIV Infection Trial (dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen)

Not yet recruiting
  • HIV Infection
  • dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen
  • (no location specified)
Aug 8, 2023

HIV/AIDS Trial in Paris, Chiang Mai (TDF/FTC 300mg/200mg fixed-dose combination tablets, TAF/FTC 25mg/200mg fixed-dose

Not yet recruiting
  • HIV/AIDS
  • TDF/FTC 300mg/200mg fixed-dose combination tablets
  • TAF/FTC 25mg/200mg fixed-dose combination tablets
  • Paris, France
  • +1 more
Apr 3, 2023

HIV-1 Trial in Panama, South Africa, United States (F/TAF, 3rd ARV agent, Boosted PIs)

Active, not recruiting
Has Results
  • HIV-1
  • Los Angeles, California
  • +7 more
Nov 11, 2022

Body Weight Changes, Human Immunodeficiency Virus, ART Trial in Dallas (DOR/3TC/TDF, DOR + FTC/TAF, BIC/FTC/TAF)

Not yet recruiting
  • Body Weight Changes
  • +7 more
  • Dallas, Texas
    Prism Health North Texas
Jul 12, 2022

HIV-1-infection Trial in Kisumu, Nairobi (Switch to B/F/TAF, Continue current regimen)

Active, not recruiting
  • HIV-1-infection
  • Switch to B/F/TAF
  • Continue current regimen
  • Kisumu, Kenya
  • +1 more
May 24, 2022

SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes

Completed
  • SARS-CoV2 Infection
  • Diabetes Mellitus, Type 1
  • venous blood sample
  • Llantrisant, Rhondda Cynon Taf, United Kingdom
    Cwm Taf Morgannwg University Health board
May 30, 2022

Health-related Quality of Life in HIV-1 Infected Adults

Active, not recruiting
  • HIV-1-infection
  • B/F/TAF
  • Haifa, Israel
  • +4 more
Mar 8, 2022

Health-related Quality of Life in HIV-1 Infected Adults

Active, not recruiting
  • HIV-1-infection
  • Montréal, Canada
  • +5 more
Sep 22, 2022

HIV Trial in Birmingham, Pittsburgh (TAF/EVG Insert)

Completed
  • HIV Infections
  • TAF/EVG Insert
  • Birmingham, Alabama
  • +1 more
Apr 20, 2022

HIV Trial in Roma (Antiviral Agents)

Not yet recruiting
  • HIV Infections
  • Antiviral Agents
  • Roma, Italy
    Fondazione PoliclinicoAgostino Gemelli IRCCS
Feb 9, 2023

Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma

Recruiting
  • Sexually Transmitted Diseases, Bacterial
  • Antibiotic Resistant Infection
    • Llantrisant, Rhondda Cynon Taf, United Kingdom
    • +1 more
    May 20, 2022

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

    Not yet recruiting
    • Chronic Hepatitis b
    • Anti-PD-1 Antibody
    • Anti-PD-1 antibody
    • NAs
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 3, 2023

    Bictegravir in the Elderly Living With HIV (BICEP)

    Active, not recruiting
    • HIV-1-infection
    • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
    • Buffalo, New York
      Evergreen Health
    Oct 28, 2022

    HIV-1-infection Trial in L'Hospitalet De Llobregat (Doravirine, Descovy)

    Completed
    Has Results
    • HIV-1-infection
    • L'Hospitalet De Llobregat, Barcelona, Spain
      Hospital Universitari de Bellvitge
    Apr 27, 2022

    HIV-1-infection Trial in Palm Springs (B/F/TAF)

    Recruiting
    • HIV-1-infection
    • Palm Springs, California
      DAP Health
    Dec 6, 2021

    Healthy, Hepatitis B, Chronic Trial in Grafton (JNJ-64457744, Placebo, Tenofovir Disoproxil Fumarate (TDF))

    Recruiting
    • Healthy
    • Hepatitis B, Chronic
    • Grafton, New Zealand
      New Zealand Clinical Research
    Aug 11, 2022

    HIV-1-infection Trial in Liuzhou, Najing, Tianjin (B/F/TAF, TDF/3TC/EFV)

    Recruiting
    • HIV-1-infection
    • Liuzhou, Guangxi, China
    • +2 more
    Mar 31, 2022